Referencje

Dear Dr Jurczyszyn,

My apologies to you for being so tardy in corresponding with you.

The concept of having a Myeloma Treatment Foundation to support a center for myeloma treatment in Poland is a superb idea. With the explosion of newer treatments for myeloma, it is critical that there be a central medical facility with knowledge in the malignancy, since the opportunities for treatment are vast, but complicated. It is not possible for the average oncologist, hematologist, or cancer center to provide the finesse and extra expertise required for optimal treatment of patients with myeloma. Further, concentrating patients in one facility allows research to be performed in a meaningful way that will help advance the field forward.

I am aware of the outstanding work you have already achived in myeloma therapy and believe the establishment of such a center in Poland would not only expedite the optimal care of myeloma patients in the area, but would also enhance the reputation of Polish medicine.

I do wish you the best of luck in your efforts, and do hope that you will continue to make your seminal observations in this malignant disease where major inroads to its effective treatment are occurring in an ever increasing frequency.

My very best regards,

Morton Coleman, M.D.
Director, Center for Lymphoma and Myeloma
New York Presbyterian Hospital-Cornell Medical Center
Clinical Professor of Medicine
Weill Medical College of Cornell University
407 East 70th Street, 3rd Floor, New York, New York 10021
(o) 212 746 6822, (f) 212 734 9238, (m) 914 643 9103
e-mail: mortoncolemanmd@aol.com

MD Anderson Cancer Center » PDF
The University Of Texas
Raymond Alexanian, M.D.
Professor of Medicine
Department of Myeloma/Lymphoma
1515 Holcombe Blvd, Unit 429 Houston, Texas 77030
Tel.: (713) 794-3234    Fax: (713) 563-5067
e-mail: ralexani@mdanderson.org

Dipartimento di Medicina ed Oncologia Sperimentale » PDF
Universita’ Degli Studi di Torino

Antonio Palumbo, MD
Via Genova 3 – 10126 Torino – Italy
Tel.: +39-011-6635814 / 6633012 / 6336728    Fax: +39-011-6963737
e-mail: mario.boccadoro@unito.it

Dana-Farber Cancer Institute » PDF
Brigham And Women’s Hospital
Paul G. Richardson, M.D.
Clinical Director, Jerome Lipper Multiple Myeloma Center
Department of Medical Oncology
Associate Professor in Medicine Harvard Medical School
e-mail: paul_richardson@dfci.harvard.edu
www.dana-farber.org

Erasmus MC – University Medical Center Rotterdam » PDF

Prof. Dr. Peter Sonneveld
Hematology and internal medicine specjalist
Erasmus University Hospital
Przewodniczący The European Myeloma Network
e-mail: p.sonneveld@erasmusmc.nl

Mayo Clinic College of Medicine » PDF

Robert A. Kyle M.D.
Professor of Medicine, Laboratory Medicine and Pathology
Mayo Clinic College of Medicine
President, International Myeloma Society

Morie A. Gertz M.D.
Chairman, Department of Medicine
Professor of Medicine, Mayo Clinic College of Medicine
Treasurer, International Myeloma Society

Weill Cornell Medical College » PDF
New York-Presbyterian Hospital, Weill Cornell Medical Center
Ruben Niesvizky M.D.
Clinical Director, Multiple Myleoma Service
Associate Professor of Clinical Medicine
Division of Hematology & Medical Oncology
Telephone: 212-746-3964    Fax: 212-746-5536

Dana-Farber Cancer Institute » PDF
Brigham And Women’s Hospital
Kenneth C. Anderson, MD.
Kraft Family Professor of Medicine Harvard Medical School
Chief, Division of Hematologic Neoplasia
Director, LeBow Institute for Myeloma Therapeutics
Director, Jerome Lipper Multiple Myeloma Center
Vice Chair, Program in Transfusion Medicine
Department of Medical Oncology
e-mail: kenneth_anderson@dfci.harvard.edu
www.dana-farber.org